Hyaluronic acid API Manufacturers & Suppliers

Hyaluronic acid is used in intra‑articular products to reduce knee pain associated with osteoarthritis by restoring synovial viscosity. It is included in ophthalmic formulations for dry eye and surgical lubrication, and in topical, oral, and injectable products for wound care and symptomatic skin irritation. It also serves as a dermal filler to address volume loss and facial contour changes and is used intravesically for symptomatic relief in interstitial cystitis.

Hyaluronic acid belongs to the following therapeutic categories: Adjuvants, Immunologic, Biocompatible Materials, Carbohydrates, Cicatrizants, Compounds used in a research, industrial, or household setting. This positioning helps teams compare alternative APIs, anticipate pharmacology expectations, and align early research priorities.

The primary indications for Hyaluronic acid: The intra-articular preparations of Hyaluronic acid are indicated for knee pain associated with osteoarthritis, Hyaluronic acid is used in cosmetic applications to prevent and reduce the appearance of wrinkles on the face, and as a dermal filler to correct facial imperfections or other imperfections on other parts of the body, It is frequently an ingredient in topical applications for wound healing and symptomatic treatment of skin irritation from various causes, Hyaluronic acid may also be indicated in ophthalmological preparations or oral capsules to treat discomfort caused by dry eyes or conjunctivitis and for its protective qualities during and before eye surgery. These use cases frame the target patient populations and help prioritize formulation and safety evaluations.

General principles and Hyaluronic acid receptor binding Hyaluronic acid works by two basic mechanisms: serving as a passive structural molecule or serving as signaling molecule, depending on the molecule size. The physicochemical properties of high molecular weight HA contribute to passive structural effects, demonstrating hygroscopicity and viscoelasticity and improving hydration, water balance, and structural integrity. As a signalling molecule interacting with proteins, HA causes several opposing effects based on molecular weight: pro- or anti-inflammatory effects, promotion or inhibition of cell migration, and activating or inhibiting cell division. Hyaluronic acid exerts its therapeutic effects through binding to three primary types of cell surface receptors: CD44 (a membrane glycoprotein), the receptor for hyaluronate-mediated motility (RHAMM), and the Intercellular Adhesion Molecule 1 (ICAM-1). CD44 is considered the most widely distributed receptor for Hyaluronic acid, demonstrating cellular interactions with osteopontin, collagen, and matrix metalloproteinases (MMPs). High and low molecular weight Hyaluronic acids demonstrate differing molecular and cellular mechanisms in their interaction with CD44 receptors. Some examples of these effects include modification of chondrocyte survival pathways in addition to alteration of apoptosis pathways. Lymphatic vessel endothelial hyaluronan receptor (LYVE-1), and Hyaluronic acid receptor for endocytosis (HARE), (also known as Stabilin-2) also bind to Hyaluronic acid. Hyaluronic acid for skin conditions and cosmetics Hyaluronic acid's anionic proprieties cause it to attract water and induce swelling, increasing tissue volume and skin structural integrity. The aging process is associated with reduced production of skin Hyaluronic acid and collagen, causing the appearance of wrinkles and the loss of facial volume. Dermal fillers of Hyaluronic acid replace lost tissue volume, imparting a full and youthful appearance to skin that has lost its elasticity. Hyaluronic acid fillers contain cross-linked Hyaluronic acid particles, rendering a concentrated substance with resistance to various forms of physical and chemical breakdown. The cosmetic benefits of Hyaluronic acid filler may last up to 6 months, depending on the brand and technique used for injection.Additionally, dermal Hyaluronic acid fillers are known to increase the production of fibroblasts, supporting wound healing and offering relief from irritating and inflammatory skin conditions. Hyaluronic acid for joint pain Most cells in the human body are capable of synthesizing HA. It is a primary component of the extracellular matrix (ECM) and can be found in bone marrow, cartilage, and synovial fluid in joints.In osteoarthritis, the concentration of naturally occurring Hyaluronic acid gradually decreases, lowering the viscosity of synovial fluid that protects joints from excess friction. Administration of intra-articular Hyaluronic acid increases viscosity of synovial joint fluid, reducing friction and subsequently relieving painful arthritic symptoms. Hyaluronic acid for ophthalmic conditions and ophthalmological procedures Solutions of Hyaluronic acid with a concentration greater than 0.1% moisturize the surface of the eyes to treat symptoms of dry eye while improving the stabilization of tear film, replenishing deficiencies of HA, reducing friction, and preventing binding of foreign substances to the ocular tissue.Hyaluronic acid is frequently used during and after ophthalmological surgeries and plays important roles by virtue of its moisturizing, viscoelastic, and protective properties. It promotes tissue healing of the corneal epithelium and other parts of the eye following ophthalmological surgery, minimizing the risk of adhesions and free radical formation.

Hyaluronic acid has a favorable safety profile, with low acute oral toxicity and an LD50 greater than 800 mg/kg in rats for the sodium salt. Most adverse effects are local and route‑dependent, such as transient inflammation, injection‑site reactions, edema, or nodule formation with dermal fillers. Rare but serious events have been reported after improper injections, including pseudoseptic reactions in joints and severe outcomes from uncontrolled vaginal procedures. Systemic toxicity is minimal due to local administration and enzymatic degradation into smaller fragments cleared through lymphatic and hepatic pathways.

Formulation should account for its high hydrophilicity and molecular‑weight–dependent viscosity, which influence gel behavior, syringeability, and absorption. Parenteral and intra‑articular preparations require tight control of molecular‑weight distribution, endotoxin levels, pH, and shear exposure to maintain consistent rheology. Oral and topical products rely on its water solubility and gel‑forming properties, with stability focused on preventing microbial contamination.

Hyaluronic acid is classified as a small molecule. That classification shapes process design, impurity profiling, and analytical control strategies.

Oral Hyaluronic acid is generally stable because it is highly water‑soluble, and its degradation in products is driven more by microbial contamination than by chemical breakdown. Maintaining adequate preservative systems and controlling moisture and bioburden are the primary stability considerations. Sensitivity to shear and pH seen in parenteral solutions is less critical for oral products, where viscosity is not a key performance attribute.